142 related articles for article (PubMed ID: 24015230)
21. Tyrosine phosphatase PTPα contributes to HER2-evoked breast tumor initiation and maintenance.
Meyer DS; Aceto N; Sausgruber N; Brinkhaus H; Müller U; Pallen CJ; Bentires-Alj M
Oncogene; 2014 Jan; 33(3):398-402. PubMed ID: 23318421
[TBL] [Abstract][Full Text] [Related]
22. The rho exchange factors vav2 and vav3 control a lung metastasis-specific transcriptional program in breast cancer cells.
Citterio C; Menacho-Márquez M; García-Escudero R; Larive RM; Barreiro O; Sánchez-Madrid F; Paramio JM; Bustelo XR
Sci Signal; 2012 Oct; 5(244):ra71. PubMed ID: 23033540
[TBL] [Abstract][Full Text] [Related]
23. Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1.
Hunter KW; Broman KW; Voyer TL; Lukes L; Cozma D; Debies MT; Rouse J; Welch DR
Cancer Res; 2001 Dec; 61(24):8866-72. PubMed ID: 11751410
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic reprogramming governs EcSOD expression during human mammary epithelial cell differentiation, tumorigenesis and metastasis.
Teoh-Fitzgerald ML; Fitzgerald MP; Zhong W; Askeland RW; Domann FE
Oncogene; 2014 Jan; 33(3):358-68. PubMed ID: 23318435
[TBL] [Abstract][Full Text] [Related]
25. Gene expression and epigenetic profiles of mammary gland tissue: insight into the differential predisposition of four rat strains to mammary gland cancer.
Luzhna L; Kutanzi K; Kovalchuk O
Mutat Res Genet Toxicol Environ Mutagen; 2015 Feb; 779():39-56. PubMed ID: 25813725
[TBL] [Abstract][Full Text] [Related]
26. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
27. Pathways contributing to development of spontaneous mammary tumors in BALB/c-Trp53+/- mice.
Yan H; Blackburn AC; McLary SC; Tao L; Roberts AL; Xavier EA; Dickinson ES; Seo JH; Arenas RB; Otis CN; Cao QJ; Lawlor RG; Osborne BA; Kittrell FS; Medina D; Jerry DJ
Am J Pathol; 2010 Mar; 176(3):1421-32. PubMed ID: 20110418
[TBL] [Abstract][Full Text] [Related]
28. Ink4a/Arf(-/-) and HRAS(G12V) transform mouse mammary cells into triple-negative breast cancer containing tumorigenic CD49f(-) quiescent cells.
Kai K; Iwamoto T; Kobayashi T; Arima Y; Takamoto Y; Ohnishi N; Bartholomeusz C; Horii R; Akiyama F; Hortobagyi GN; Pusztai L; Saya H; Ueno NT
Oncogene; 2014 Jan; 33(4):440-8. PubMed ID: 23376849
[TBL] [Abstract][Full Text] [Related]
29. Mouse models of breast cancer.
Sakamoto K; Schmidt JW; Wagner KU
Methods Mol Biol; 2015; 1267():47-71. PubMed ID: 25636464
[TBL] [Abstract][Full Text] [Related]
30. Comparing genetically engineered mouse mammary cancer models with human breast cancer by expression profiling.
Shoushtari AN; Michalowska AM; Green JE
Breast Dis; 2007; 28():39-51. PubMed ID: 18057542
[TBL] [Abstract][Full Text] [Related]
31. A mouse model for luminal epithelial like ER positive subtype of human breast cancer.
Kumar MJ; Ponvijay KS; Nandhini R; Nagarajan RS; Jose J; Srinivas G; Nagarajan P; Venkatesan R; Kumar K; Singh S
BMC Cancer; 2007 Sep; 7():180. PubMed ID: 17880731
[TBL] [Abstract][Full Text] [Related]
32. Stress-resistant Translation of Cathepsin L mRNA in Breast Cancer Progression.
Tholen M; Wolanski J; Stolze B; Chiabudini M; Gajda M; Bronsert P; Stickeler E; Rospert S; Reinheckel T
J Biol Chem; 2015 Jun; 290(25):15758-15769. PubMed ID: 25957406
[TBL] [Abstract][Full Text] [Related]
33. Transformation of enriched mammary cell populations with polyomavirus middle T antigen influences tumor subtype and metastatic potential.
Drobysheva D; Smith BA; McDowell M; Guillen KP; Ekiz HA; Welm BE
Breast Cancer Res; 2015 Oct; 17(1):132. PubMed ID: 26429062
[TBL] [Abstract][Full Text] [Related]
34. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.
Herschkowitz JI; Simin K; Weigman VJ; Mikaelian I; Usary J; Hu Z; Rasmussen KE; Jones LP; Assefnia S; Chandrasekharan S; Backlund MG; Yin Y; Khramtsov AI; Bastein R; Quackenbush J; Glazer RI; Brown PH; Green JE; Kopelovich L; Furth PA; Palazzo JP; Olopade OI; Bernard PS; Churchill GA; Van Dyke T; Perou CM
Genome Biol; 2007; 8(5):R76. PubMed ID: 17493263
[TBL] [Abstract][Full Text] [Related]
35. MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression.
Christenson JL; Butterfield KT; Spoelstra NS; Norris JD; Josan JS; Pollock JA; McDonnell DP; Katzenellenbogen BS; Katzenellenbogen JA; Richer JK
Horm Cancer; 2017 Apr; 8(2):69-77. PubMed ID: 28194662
[TBL] [Abstract][Full Text] [Related]
36. Stromally derived lysyl oxidase promotes metastasis of transforming growth factor-β-deficient mouse mammary carcinomas.
Pickup MW; Laklai H; Acerbi I; Owens P; Gorska AE; Chytil A; Aakre M; Weaver VM; Moses HL
Cancer Res; 2013 Sep; 73(17):5336-46. PubMed ID: 23856251
[TBL] [Abstract][Full Text] [Related]
37. E2f3 in tumor macrophages promotes lung metastasis.
Trikha P; Sharma N; Pena C; Reyes A; Pécot T; Khurshid S; Rawahneh M; Moffitt J; Stephens JA; Fernandez SA; Ostrowski MC; Leone G
Oncogene; 2016 Jul; 35(28):3636-46. PubMed ID: 26549026
[TBL] [Abstract][Full Text] [Related]
38. Dysfunctional telomeres promote genomic instability and metastasis in the absence of telomerase activity in oncogene induced mammary cancer.
Bojovic B; Crowe DL
Mol Carcinog; 2013 Feb; 52(2):103-17. PubMed ID: 22086874
[TBL] [Abstract][Full Text] [Related]
39. Mena deficiency delays tumor progression and decreases metastasis in polyoma middle-T transgenic mouse mammary tumors.
Roussos ET; Wang Y; Wyckoff JB; Sellers RS; Wang W; Li J; Pollard JW; Gertler FB; Condeelis JS
Breast Cancer Res; 2010; 12(6):R101. PubMed ID: 21108830
[TBL] [Abstract][Full Text] [Related]
40. Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status.
Jiang Z; Deng T; Jones R; Li H; Herschkowitz JI; Liu JC; Weigman VJ; Tsao MS; Lane TF; Perou CM; Zacksenhaus E
J Clin Invest; 2010 Sep; 120(9):3296-309. PubMed ID: 20679727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
